Healthcare
-

There is a clinical trial running right now in which GLP-1 drugs, the same molecules behind Ozempic and Wegovy, are being tested for their effect on emotional blunting. Separately, consumer neurostimulation headsets are being marketed to flatten anxiety on demand. A startup in San Francisco is offering a subscription that adjusts your baseline mood the…


